Richter says FDA request likely to delay new antipsychotic drug
November 21, 2013 at 05:19 AM EST
BUDAPEST, Nov 21 (Reuters) - An information request from U.S. health authorities is likely to delay the entry of a new antipsychotic drug from Forest Laboratories and Hungary's Richter, a Richter spokeswoman said on Thursday.
